AccessibilityHelp

Davion Healthcare Plc(NASDAQ) DAVI

Market Cap$150.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-49%
5 YearN/A
1 YearN/A
1 MonthN/A
$6.00
-48.50%
-5.65Today
After hours$5.69-$0.31 (-5.17%)
Davion Healthcare Plc last closing stock price
MetricPriceDate
Last closeUSD 6.002026-10-23
Davion Healthcare Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
Since inception-48.5%USD 11.652026-10-22

Davion Healthcare Plc Financials at a Glance

Market Cap

$150.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$6.00

Volume

479,470

Open

$8.89

Previous Close

$6.00

Daily Range

$5.67 - $8.89

52-Week Range

$5.67 - $12.30

Estimated Earnings Date

N/A

DAVI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Davion Healthcare Plc

Davion Healthcare Plc is an innovative Irish public limited company focused on developing non-invasive home tests for early detection of health anomalies, including cancers. Utilizing advanced thermography and AI analysis, Davion aims to revolutionize health monitoring and diagnostics.

Products and Services
  • BreastCheck: Non-invasive test for early breast cancer detection
  • FootFlow: Monitors diabetic circulation through thermography
  • Testic and ThermaDerm: Additional non-diagnostic Class I devices
Growth Outlook
  • Global manufacturing agreement with NeuRX Health Inc. enhances market reach
  • Plans for acquisitions of complementary healthcare businesses to expand portfolio
  • £30 million bond issuance supports product commercialization and growth initiatives
Financial Highlights
  • Market capitalization stands at $150 million, indicating strong investor interest
  • Stock price range between $5.67 and $12.3 reflects potential for growth
  • Volume of 479,470 shares traded shows active market participation
Davion Healthcare Plc is positioned at the forefront of the medical devices industry, focusing on non-invasive testing solutions that leverage cutting-edge technology. The company's innovative products, such as BreastCheck and FootFlow, have gained regulatory approvals, enhancing their credibility and marketability. The strategic partnership with NeuRX Health Inc. not only provides substantial financial backing but also facilitates broader distribution channels. The company's growth strategy includes potential acquisitions, which could further diversify its offerings and strengthen its market position. The recent bond issuance is a significant step towards funding these initiatives, showcasing Davion's commitment to expanding its footprint in the healthcare sector. With a solid market capitalization and active trading volume, Davion Healthcare Plc presents an intriguing opportunity for investors interested in the evolving landscape of medical diagnostics. The company's focus on early detection technologies aligns with growing global health trends, making it a noteworthy player in the healthcare industry.
AI Generated • Oct 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Jack Harry Kaye

Website

www.davionhealthcare.com

Headquarters

Cork, T12 H1XY, IE

DAVI Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$150.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

25.00M

Volume

479.47K

Avg. Volume

518.94K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Davion Healthcare Plc Performance Analysis

Davion Healthcare Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
Davion Healthcare Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31USD -0.23N/A
20242024-12-31USD -0.06-75.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$150.00MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,623.68-0.01%
^DJIDJI
$52,215.16-0.01%
^IXICNASDAQ
$25,955.34-0.00%
BTCBitcoin
$80,657.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About DAVI

What is the current price of Davion Healthcare Plc?

Davion Healthcare Plc is trading at $6.00 per share.

What is the 52-week range for Davion Healthcare Plc?

Over the past 52 weeks, Davion Healthcare Plc has traded between $5.67 and $12.30.

How much debt does Davion Healthcare Plc have?

As of the most recent reporting period, Davion Healthcare Plc reported total debt of $0.00.

How much cash does Davion Healthcare Plc have on hand?

Davion Healthcare Plc reported $11.39 in cash and cash equivalents in its most recent financial results.

What is Davion Healthcare Plc’s dividend yield?

Davion Healthcare Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services